Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma.

NPJ Precis Oncol · 2025 · PMC11885445 · PMID 40050446

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While RFS survival was statistically significantly longer in patients who were downstaged compared to those who were not, OS did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.